FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Delayed Börse Stuttgart 10:48:53 2024-05-23 EDT | ||
| 10.02 EUR | -6.09% |
|
| Current month | +6.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 10.02 | -6.09% |
| 24-05-22 | 10.67 | +1.04% |
| 24-05-21 | 10.56 | -3.39% |
| 24-05-20 | 10.93 | +0.64% |
| 24-05-17 | 10.86 | +1.69% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 10:48 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2WPU |
| ISIN | DE000MG2WPU3 |
| Date issued | 2024-04-24 |
| Strike | 509.9 p |
| Maturity | Unlimited |
| Parity | 0.56 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.95 € |
|---|---|
| Lowest since issue | 9.54 € |
| Spread | 0.03 € |
| Spread % | 0.30% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92
USD
Average target price
16.31
USD
Spread / Average Target
+26.28%
- Stock Market
- Certificates
- Certificat
